Results 181 to 190 of about 747,119 (356)

Activated Partial Thromboplastin Time Clot Waveform Analysis In Hemophilia A

Journal of Taibah University Medical Sciences, 2023
Maha Said, Amani Jabri, Ons Ghali, Fatma Ben Lakhal, Sarra Fekih Salem, Emna Gouider, Wijdene El Borgi   +6 more
doaj  

Comparative analysis on characteristics of two activated partial thromboplastin time reagents. [PDF]

J Clin Lab Anal, 2022
Yasui Y, Ishii T, Tatebe J, Morita T.
europepmc   +1 more source

High Prevalence of Platelet Function Disorders in Women Referred for Surgical Management of Refractory Heavy Menstrual Bleeding

Haemophilia, EarlyView.
ABSTRACT Introduction Heavy menstrual bleeding (HMB) is a common presenting symptom in women with bleeding disorders, yet haemostatic testing is sometimes overlooked, even when refractory HMB requires surgical intervention. Aim To determine the prevalence of bleeding disorders in women referred for surgical management of HMB and investigate screening ...
Alison Delaney, Evangelos I. Kritsotakis, Kevin Horner, Steve Kitchen, Jennifer Sedcole, Ted Baxter, Rhona M. Maclean, Michael Makris, Clare V. Samuelson   +8 more
wiley   +1 more source

Coronary Artery Disease Presentation and Its Association with Shortened Activated Partial Thromboplastin Time

Journal of Tehran University Heart Center, 2018
Background: Standard coagulation screening tests are important constituents of basic examinations in clinical laboratories. There is no clear evidence of a relation between the type of clinical presentation and coagulation parameters in patients with ...
Maryam Sotoudeh Anvari, Mojgan Tavakoli, Masoumeh Lotfi-Tokaldany, Mohammadali Broumand, Omid Rezahosseini, Elham Hakki-Kazzazi, Arash Jalali   +6 more
doaj  

A Patient with Severe Fever with Thrombocytopenia Syndrome, Activated Partial Thromboplastin Time Prolongation, and Transient Antiphospholipid Antibodies. [PDF]

Intern Med, 2023
Tsukamoto Y, Sugimoto T, Umeda M, Kato T, Hiura Y, Morita K, Ariyoshi K.   +6 more
europepmc   +1 more source

Profiling of Anti‐FVIII Antibodies in Acquired Haemophilia A: ‘Insights into Domain Specificity, Isotype Variability, and Clinical Correlations’

Haemophilia, EarlyView.
ABSTRACT Introduction Acquired haemophilia A (AHA) is a rare autoimmune disorder caused by autoantibodies against coagulation factor VIII (FVIII), resulting in significant bleeding risks. Aim To characterize the anti‐FVIII antibody profile in AHA patients by assessing isotypes, subclasses, and correlations with key clinical parameters.
Ann‐Cristin Berkemeier, Isabell Matuschek, Katrin Hartlieb, Thilo Albert, Natascha Marquardt, Johannes Oldenburg, Behnaz Pezeshkpoor   +6 more
wiley   +1 more source

Comparison of Time Within Therapeutic Range Using Anti-Factor Xa Versus Activated Partial Thromboplastin Time Monitoring of Unfractionated Heparin in Children. [PDF]

J Pediatr Pharmacol Ther, 2023
Haftmann RJ, Pineda EM, Hall BA, Wilson MD, Mateev SN.   +4 more
europepmc   +1 more source

Aprotinin Prolongs Whole Blood Activated Partial Thromboplastin Time but Not Whole Blood Prothrombin Time in Patients Undergoing Cardiac Surgery

, 1995
George J. Despotis, Alexander Alsoufiev, Lawrence T. Goodnough, Demetrios G. Lappas   +3 more
openalex   +1 more source

Effectiveness and safety of antithrombin for treatment of portal vein thrombosis: Nationwide prospective surveillance of 4 years of clinical experience in Japan

Hepatology Research, EarlyView.
Abstract Aim Antithrombin (AT), a plasma protein with anticoagulant properties, has a long‐standing medical history, primarily for treatment of congenital AT deficiency. Accumulated clinical experiences suggest AT is a potential anticoagulant for thrombotic diseases. This study aimed to clarify the effectiveness, safety, and clinical significance of AT
Shoichi Matsutani, Makoto Arakawa, Susumu Nakano   +2 more
wiley   +1 more source

Activated Partial Thromboplastin Time and Risk of Future Venous Thromboembolism [PDF]

, 2008
Neil A. Zakai, Tetsuya Ohira, Richard White, Aaron R. Folsom, Mary Cushman   +4 more
openalex   +3 more sources